Relay Therapeutics, Inc. (RLAY) Presents at ISSVA World Congress 2026: The Latest in Vascular Anomalies - Slideshow
Relay Therapeutics Inc RLAY
$13.54
▼ -0.88%
($-0.12)
Open
$13.53
Prev Close
$13.66
Day Range
$13.40 – $13.95
52W Range
$2.75 – $17.32
Market Cap
$2.59B
Beta
1.71
EPS (TTM)
$-1.57
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-07-16 |
| Shares Out. | 191,590,000 |
| Website | relaytx.com/ ↗ |
| Phone | 13026587581 |
Relay Therapeutics Inc is a publicly traded company under the ticker symbol RLAY on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
19 analysts (2026-05-01)
📰 Latest News for RLAY
Advance Auto Parts Posts Upbeat Q1 Earnings, Joins IBM, Ralph Lauren And Other Big Stocks Moving Higher On Thursday
Relay Therapeutics: Encouraging Data, Competitive Risks (Downgrade)
Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies - Slideshow
Barclays Maintains Overweight on Relay Therapeutics, Raises Price Target to $27
Citizens Maintains Market Outperform on Relay Therapeutics, Raises Price Target to $21
Lowe's, ZTO Express, Viavi Solutions And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Relay Therapeutics: Zovegalisib Is Becoming A Platform In Disguise